Sacrococcygeal chordoma: Review of 50 consecutive patients

被引:56
作者
Chandawarkar, RY [1 ]
机构
[1] TATA MEM HOSP,DEPT SURG ONCOL,BREAST BONE & SOFT TISSUE SERV,BOMBAY 400012,MAHARASHTRA,INDIA
关键词
D O I
10.1007/s002689900110
中图分类号
R61 [外科手术学];
学科分类号
摘要
Fifty consecutive patients with sacrococcygeal chordomas treated during 1941-1991 at the Tata Memorial Hospital in India were studied retrospectively. Pain was the commonest presenting symptom (82%). An average time lapse of 14 months between the onset of pain and definitive diagnosis emphasizes the importance of a high index of suspicion and prompt use of sophisticated imaging techniques Leading to an early diagnosis. All patients underwent a partial sacrococcygectomy, through a sacral approach in 22 patients (44%) and an abdominosacral approach in 28 (56%). Postoperative complications included urinary incontinence (14%), rectal incontinence (6%), hemorrhage (4%), and rectal injury (2%). Radiotherapy offered significant pain relief to patients with widespread recurrence. A total of 38 patients were ambulatory, and 12 needed support. The average disease-free survival was 63 months, and the overall survival was 7 gears. Aggressive resection through a combined abdominosacral approach offers the best results. Because postrecurrence salvage rates are poor, the primary surgery must be complete and curative.
引用
收藏
页码:717 / 719
页数:3
相关论文
共 18 条
[1]   DIAGNOSIS AND MANAGEMENT OF SACROCOCCYGEAL CHORDOMA [J].
BETHKE, KP ;
NEIFELD, JP ;
LAWRENCE, W .
JOURNAL OF SURGICAL ONCOLOGY, 1991, 48 (04) :232-238
[2]   CHORDOMA - THE RESULTS OF MEGAVOLTAGE RADIATION-THERAPY [J].
CUMMINGS, BJ ;
HODSON, DI ;
BUSH, RS .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1983, 9 (05) :633-642
[3]  
DAHLIN DC, 1952, CANCER, V5, P1170, DOI 10.1002/1097-0142(195211)5:6<1170::AID-CNCR2820050613>3.0.CO
[4]  
2-C
[5]   RADIOTHERAPY FOR CHORDOMA [J].
FULLER, DB ;
BLOOM, JG .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1988, 15 (02) :331-339
[6]  
GRAY SW, 1975, SURGERY, V78, P573
[7]  
GUNTERBERG B, 1975, INVEST UROL, V13, P183
[8]  
HIGINBOTHAM NL, 1967, CANCER-AM CANCER SOC, V20, P1841, DOI 10.1002/1097-0142(196711)20:11<1841::AID-CNCR2820201107>3.0.CO
[9]  
2-2
[10]  
HOROWITZ T, 1941, ARCH PATHOL LAB MED, V31, P354